Expert Review of Neurotherapeutics
(ISSN: 1473-7175, 1744-8360)
Expert Review of Neurotherapeutics is published monthly providing expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's disease and Parkinson's disease.
The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections:
Expert commentary - a personal view on the most effective or promising strategies; Five-year view - a clear perspective of future prospects within a realistic time scale; Key issues - an executive summary cutting to the author's most critical points
Articles are subject to peer-review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article.
The journal welcomes unsolicited review proposals.